Sinphar Pharmaceutical Co. Ltd. Sinphar Pharmaceutical Co. Ltd.

Sinphar Pharmaceutical Co. Ltd.

1734

Rank in Stocks #16759
Sinphar Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the... Sinphar Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the production, processing, selling, and trading of various medicines, chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally. It operates through three segments: Pharmaceuticals, Healthy Food, and Others. The company offers pharmaceutical products, including antineoplastic, ophthalmic, ENT, oral, respiratory system, dermatology, analgesic and NSAIDs, metabolic and nutrient, gastrointestinal, and other products; and healthy food under the Sinphar, DailyCare, Migus, YouBest, and SynCoreBio brands. It also provides moisturizer repair essence, anti aging cream, renewable oi, and UV defence cream under the DYNASKIN brand; serum, revitalizing cream, hygiene, sunblock, sunscreen, and lightening tables under the Yestuner brand; and shower gel and hair shampoo. In addition, the company is involved in the provision of testing and development, as well as product design and manufacturing services. The company was incorporated in 1977 and is based in Yilan City, Taiwan.
Share Price
$0.86811624
Last synced: 2026-11-19
Market Cap
$185.40M
Change (1 day)
-1.78%
Change (1 year)
-5.39%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade Sinphar Pharmaceutical Co. Ltd. (1734)

Category

Healthcare
EPS for Sinphar Pharmaceutical Co. Ltd. (1734)
EPS as of September 2026 TTM: $0.05
According to Sinphar Pharmaceutical Co. Ltd.'s latest financial reports, its current EPS (TTM) is $0.05. At the end of 2025 the company had an EPS of $0.06, an increase over its 2024 EPS of $0.05.
EPS history for Sinphar Pharmaceutical Co. Ltd. from 2004 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $0.05 -11.83%
2025 $0.06 19.53%
2024 $0.05 -24.15%
2023 $0.07 67.08%
2022 $0.04 -631.58%
2021 $-0.01 33.33%
2020 $-0.01 -311.11%
2019 0.00 58.82%
2018 0.00 -77.03%
2017 $0.01 138.71%
2016 0.00 29.17%
2015 0.00 -92.16%
2014 $0.03 -48.91%
2013 $0.06 134.90%
2012 $0.03 57.41%
2011 $0.02 -38.64%
2010 $0.03 -13.73%
2009 $0.03 194.23%
2008 $0.01 -42.86%
2007 $0.02 85.71%
2006 $0.01 -73.66%
2005 $0.04 18.10%
2004 $0.03 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$1.69 3,094.71%
US
$1.90 3,489.41%
SE
$6.83 12,819.85%
FR
$0.02 -63.14%
HK
$2.81 5,213.80%
IT

Questions about Sinphar Pharmaceutical Co. Ltd.'s earnings per share (EPS)

What is Sinphar Pharmaceutical Co. Ltd.'s earnings per share (EPS)?

Sinphar Pharmaceutical Co. Ltd.'s earnings per share (EPS) over the last twelve months is $0.05, as of Sep 2026.

What was Sinphar Pharmaceutical Co. Ltd.'s earnings per share (EPS) in 2025?

In 2025, Sinphar Pharmaceutical Co. Ltd.'s earnings per share (EPS) was $0.06, 20.00% more than in 2024 ($0.05).

How has Sinphar Pharmaceutical Co. Ltd.'s earnings per share (EPS) changed since 2020?

From 2020 to 2025, Sinphar Pharmaceutical Co. Ltd.'s earnings per share (EPS) was highest in 2023 ($0.07) and lowest in 2021 ($-0.01).

How does Sinphar Pharmaceutical Co. Ltd.'s earnings per share (EPS) compare with similar companies?

Sinphar Pharmaceutical Co. Ltd.'s earnings per share (EPS) ($0.05) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Ipsen S.A., with $6.83.